Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

SOUTH AFRICA: Sanofi Teams Up with India to Make Cheap ARVs in South Africa


Agence France Presse (03.30.12) - Monday, April 02, 2012

Under an arrangement announced Friday, French drugmaker Sanofi will partner with India's Hetero to manufacture low-cost antiretrovirals in South Africa. The move represents progress toward South Africa's goal of buying 80 percent of its ARVs from local sources, said Sanofi CEO Christopher Viehbacher. "There is a continuous supply shortage for critical medicines for HIV/AIDS. Only 50 percent of patients are able to receive treatment, and there is a real need for more locally manufactured and supplied affordable ARVs." To accommodate increased demand, Sanofi recently upgraded its factory north of Pretoria.


Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in April 2, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.